SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects growing adoption of its SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. To view the full press release, visit https://ibn.fm/XWdRe.
This award underscores SS Innovations' mission to make robotic surgery affordable and accessible globally. The SSi Mantra system's cost efficiency compared to competitors could expand access to minimally invasive surgery in underserved regions. The company's focus on telesurgery and pediatric procedures highlights its potential to address critical healthcare gaps. As regulatory approvals expand across 14 countries, the system's growing procedure volume and physician training indicate accelerating market penetration.
However, the surgical robotics market remains competitive, with established players holding significant market share. SS Innovations' ability to sustain growth and navigate regulatory hurdles will be key to long-term success. The company's forward-looking statements caution that actual results may differ due to risks outlined in its SEC filings, including those detailed under "Risk Factors" in its annual and quarterly reports.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com for more information and updates. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer.
